ARCHIVES

Pathology Review Confirms Reserpine As Carcinogen

This article is from The Cancer Letter archive.

Vol. 06 No. 11 | March 14, 1980

Download PDF Visit The Full Archive

Related Articles

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

May 9, 2003

NCI Plans Two New RFAs For Stimulus Funds

March 6, 2009

Smoking/Health Program Seeks Grants; Ideas For RFAs RFPs Being Considered

December 5, 1980

Risk of Relapse Continues After Five Years of Therapy

August 29, 2008

Dendreon’s Provenge Approved For Prostate Cancer Treatment

April 30, 2010

Cancer Clinical Trials System Needs Comprehensive Review, NCI Director Says

July 11, 2003